Systems and methods for biomarker-based pacing
AssigneeBaroPace, Inc.
InventorMichael BURNAM
Life of this patent
Estimating the term…
Abstract
Disclosed are methods, systems, and computer-readable medium for implementing a closed-loop system for determining an adjusted physiological pacing rate based on receiving one or more biomarker levels, comparing the one or more biomarker levels to a target biomarker level, and determining an adjusted physiological pacing rate based on comparing the one or more biomarker levels to the target biomarker level.
Claims20
A method for determining an adjusted physiologic pacing rate, the method comprising:
- receiving one or more biomarker levels, wherein the biomarker levels indicate levels of at least one of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), N-terminal pro b-type natriuretic peptide (NT-proBNP), or C-type natriuretic peptide (CNP);
- comparing the one or more biomarker levels to a target biomarker level;
- and
- determining an adjusted physiologic pacing rate based on comparing the one or more biomarker levels to the target biomarker level.
A system for determining an adjusted physiologic pacing rate, the system comprising:
- at least one memory storing instructions;
- and
- at least one processor executing the instructions to perform a process, the at least one processor configured to:
- receiving one or more biomarker levels, wherein the biomarker levels indicate levels of at least one of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), N-terminal pro b-type natriuretic peptide (NT-proBNP), or C-type natriuretic peptide (CNP);
- comparing the one or more biomarker levels to a target biomarker level;
- and
- determining an adjusted physiologic pacing rate based on comparing the one or more biomarker levels to the target biomarker level.
A method for determining an adjusted physiologic pacing rate, the method comprising:
- receiving one or more physiological inputs and one or more biomarker levels, wherein the biomarker levels includes levels of at least one of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), N-terminal pro b-type natriuretic peptide (NT-proBNP), or C-type natriuretic peptide (CNP);
- comparing the one or more biomarker levels to a target biomarker level;
- comparing the one or more physiological inputs to a threshold physiological input;
- determining a first adjusted physiologic pacing rate based on comparing the one or more biomarker levels to the target biomarker level;
- determining a second adjusted physiologic pacing rate based on comparing the one or more physiological inputs to the threshold physiological input;
- determining a first weight associated with the first adjusted physiologic pacing rate;
- determining a second weight associated with the second adjusted physiologic pacing rate;
- and
- determining an output adjusted physiologic pacing rate based on the first adjusted physiologic pacing rate, the first weight, the second adjusted physiologic pacing rate, and the second weight.
Dependencies are inferred from the claim text.